These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30883676)

  • 1. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment.
    Danoy M; Bernier ML; Kimura K; Poulain S; Kato S; Mori D; Kido T; Plessy C; Kusuhara H; Miyajima A; Sakai Y; Leclerc E
    Biotechnol Bioeng; 2019 Jul; 116(7):1762-1776. PubMed ID: 30883676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of liver zonation-like transcriptomic patterns in HLCs derived from hiPSCs in a microfluidic biochip environment.
    Danoy M; Poulain S; Lereau-Bernier M; Kato S; Scheidecker B; Kido T; Miyajima A; Sakai Y; Plessy C; Leclerc E
    Biotechnol Prog; 2020 Sep; 36(5):e3013. PubMed ID: 32364651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analysis of hiPSCs-derived HLCs matured on-chip revealed patterns typical of liver regeneration.
    Danoy M; Tauran Y; Poulain S; Jellali R; Bruce J; Leduc M; Le Gall M; Gilard F; Kido T; Arakawa H; Araya K; Mori D; Kato Y; Kusuhara H; Plessy C; Miyajima A; Sakai Y; Leclerc E
    Biotechnol Bioeng; 2021 Oct; 118(10):3716-3732. PubMed ID: 33404112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of hiPSCs differentiation toward hepatocyte-like cells upon extended exposition to oncostatin.
    Danoy M; Tauran Y; Poulain S; Arakawa H; Mori D; Araya K; Kato S; Kido T; Kusuhara H; Kato Y; Miyajima A; Plessy C; Sakai Y; Leclerc E
    Differentiation; 2020; 114():36-48. PubMed ID: 32563741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term human primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher drug metabolism compared with Petri cultures.
    Jellali R; Bricks T; Jacques S; Fleury MJ; Paullier P; Merlier F; Leclerc E
    Biopharm Drug Dispos; 2016 Jul; 37(5):264-75. PubMed ID: 27037683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the transcription factors and their regulatory roles during a step-by-step differentiation of induced pluripotent stem cells into hepatocyte-like cells.
    Tauran Y; Poulain S; Lereau-Bernier M; Danoy M; Shinohara M; Segard BD; Kato S; Kido T; Miyajima A; Sakai Y; Plessy C; Leclerc E
    Mol Omics; 2019 Dec; 15(6):383-398. PubMed ID: 31612883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retaining mTeSR1 Medium during Hepatic Differentiation Facilitates Hepatocyte-Like Cell Survival by Decreasing Apoptosis.
    Hou J; Long Y; Hu B; Huang S; Xu G; Gao T; Wu F; Li Y; Wu ZK
    Cell Physiol Biochem; 2018; 51(4):1533-1543. PubMed ID: 30497075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the behavior of 2D monolayers and 3D spheroid human pancreatic beta cells derived from induced pluripotent stem cells in a microfluidic environment.
    Essaouiba A; Jellali R; Shinohara M; Scheidecker B; Legallais C; Sakai Y; Leclerc E
    J Biotechnol; 2021 Mar; 330():45-56. PubMed ID: 33617908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the transcriptomic profile of hepatic human induced pluripotent stem like cells cultured in plates and in a 3D microscale dynamic environment.
    Leclerc E; Kimura K; Shinohara M; Danoy M; Le Gall M; Kido T; Miyajima A; Fujii T; Sakai Y
    Genomics; 2017 Jan; 109(1):16-26. PubMed ID: 27913249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
    Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
    Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-Induced miR-210 Overexpression Promotes the Differentiation of Human-Induced Pluripotent Stem Cells to Hepatocyte-Like Cells on Random Nanofiber Poly-L-Lactic Acid/Poly (
    Mobarra N; Raji S; Najafi S; Kafi FK; Ferns GA; Pakzad R
    Oxid Med Cell Longev; 2021; 2021():4229721. PubMed ID: 34858546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.
    Takayama K; Inamura M; Kawabata K; Sugawara M; Kikuchi K; Higuchi M; Nagamoto Y; Watanabe H; Tashiro K; Sakurai F; Hayakawa T; Furue MK; Mizuguchi H
    J Hepatol; 2012 Sep; 57(3):628-36. PubMed ID: 22659344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic differentiation of rat induced pluripotent stem cells in vitro.
    Sun C; Hu JJ; Pan Q; Cao Y; Fan JG; Li GM
    World J Gastroenterol; 2015 Oct; 21(39):11118-26. PubMed ID: 26494966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of a co-culture micro-bioreactor device for efficient hepatic differentiation of human induced pluripotent stem cells (hiPSCs).
    Kehtari M; Zeynali B; Soleimani M; Kabiri M; Seyedjafari E
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):161-170. PubMed ID: 29703082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors.
    Ishikawa T; Kobayashi M; Yanagi S; Kato C; Takashima R; Kobayashi E; Hagiwara K; Ochiya T
    PLoS One; 2015; 10(4):e0123193. PubMed ID: 25875613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decellularized human liver extracellular matrix (hDLM)-mediated hepatic differentiation of human induced pluripotent stem cells (hIPSCs).
    Jaramillo M; Yeh H; Yarmush ML; Uygun BE
    J Tissue Eng Regen Med; 2018 Apr; 12(4):e1962-e1973. PubMed ID: 29222839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decellularized amniotic membrane Scaffolds improve differentiation of iPSCs to functional hepatocyte-like cells.
    Abazari MF; Soleimanifar F; Enderami SE; Nasiri N; Nejati F; Mousavi SA; Soleimani M; Kiani J; Ghoraeian P; Kehtari M
    J Cell Biochem; 2020 Feb; 121(2):1169-1181. PubMed ID: 31464024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.